ALLO
Allogene Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD1.85
+0.08 (+4.52%)
Rating:C-
Company Profile
CEO
Zachary Roberts
IPO Date
2018-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.77
Prev. Close
$1.77
Day Low
$1.76
Day High
$1.85
52W Low
$0.98
52W High
$4.46
Market Cap
$0.45B
Volume
4.48M